PGHL — Procter & Gamble Health Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹78.60bn
- IN₹74.42bn
- IN₹12.30bn
- 96
- 18
- 65
- 67
Annual cashflow statement for Procter & Gamble Health, fiscal year end - June 30th, INR millions except per share, conversion factor applied.
2018 December 31st | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 18 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 11,376 | 3,549 | 2,333 | 2,534 | 3,142 |
| Depreciation | |||||
| Non-Cash Items | -9,387 | -416 | -4.8 | 2.3 | 134 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3,543 | -1,073 | -156 | -1,112 | -1,197 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,304 | 2,354 | 2,473 | 1,695 | 2,360 |
| Capital Expenditures | -267 | -233 | -526 | -379 | -425 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 12,964 | 1,879 | 203 | 124 | 210 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 12,697 | 1,646 | -323 | -255 | -215 |
| Financing Cash Flow Items | -51.5 | -1,502 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -301 | -8,834 | -3,866 | -2,886 | -985 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11,093 | -4,834 | -1,716 | -1,446 | 1,160 |